(Q41465370)

English

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

scientific article published on 28 April 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force (English)

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

1 reference

based on heuristic

inferred from title

Andrew D. J. Pearson

7

object named as

A D J Pearson

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Katherine K Matthay

8

object named as

K K Matthay

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Robert C Seeger

5

object named as

R C Seeger

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

author name string

K Beiske

1

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

S A Burchill

2

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

I Y Cheung

3

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

E Hiyama

4

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

S L Cohn

6

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

International neuroblastoma Risk Group Task Force

9

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

language of work or name

0 references

publication date

28 April 2009

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

100

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

10

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

1627-1637

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Useful markers for detecting minimal residual disease in cases of neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Metastasis: recent discoveries and novel treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Molecular markers of circulating melanoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

The struggle to detect circulating DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detecting minimal residual disease in neuroblastoma patients-the present state of the art.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Circulating nucleic acids in plasma and serum: past, present and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Usefulness of tyrosine hydroxylase mRNA for diagnosis and detection of minimal residual disease in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

A systematic review of molecular and biological tumor markers in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Neuroblastoma: biological insights into a clinical enigma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Automatic detection and genetic profiling of disseminated neuroblastoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection and quantification of residual disease in chronic myelogenous leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Molecular detection of low-level disease in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

High-sensitivity immunocytologic analysis of neuroblastoma cells in paired blood and marrow samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

The contribution of marker gene studies to hemopoietic stem cell therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Gene marking and autologous bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

11 June 2018

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

3 July 2018

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Significance of molecular quantification of minimal residual disease in metastatic neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluorescence image analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696761

19 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VCN-releasable sialic acid and gangliosides in human neuroblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shedding of GD2 ganglioside by human neuroblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological detection and definition of minimal residual neuroblastoma disease in bone marrow samples obtained during or after therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605029

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6605029

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41465370&oldid=2204558957"